Siga Technologies Inc (SIGAQ) Return on Investment ROI from the fourth quarter of 2019 to fourth quarter of 2018 and for the year 2019, average high and low, overall ranking from Dec 31 2019 to Jun 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Siga Technologies Inc  (SIGAQ)


Siga Technologies Inc's ROI from its fourth quarter of 2019 to the fourth quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Siga Technologies Inc's ROI in the fourth quarter of 2019?
Siga Technologies Inc achieved a return on average invested assets (ROI) of 241.31 % in its fourth quarter of 2019, which is below Siga Technologies Inc's average return on investment, which stands at 2186.24%.

ROI decreased relative to the period ending Sep 30 2019, due to the decline in net income.

Within the Healthcare sector 255 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2019 from 0 to 6.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter
Y / Y Investment Change TTM - 108.17 % - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 107 191 192 139 -253
Return On Investment (TTM) 241.31 % 560.5 % 708.82 % 9781.84 % -
SIGAQ's Overall Ranking # 6 # 0 # 0 # #
Seq. Investment Change TTM 133.85 % 30.05 % 1304.57 % - -
Seq. Net Income Change TTM 0.68 % 2.83 % 1.78 % - -
Net Income (TTM) in Millions 379 377 366 360 -39

SIGAQ Company Profile >> Back to SIGAQ Roi Comparisons >> See Annual SIGAQ Return On Investment



Return On Investment SIGAQ's Ranking
Within: No.
Industry # 95
Sector # 256
Overall # 6

Return On Investment Statistics
High Average Low
9781.84 %
2186.24 %
-115.33 %
(Sep 30 2018)   (Mar 31 2018)







Financial Statements
Siga Technologies Inc's IV. Quarter Investments $ 107 Millions SIGAQ's Balance sheet
Siga Technologies Inc's IV. Quarter Income $ -5 Millions Quarterly SIGAQ's Income Statement
SIGAQ's Income by Division See SIGAQ's Income by Division


SIGAQ Annual Return On Investment (Dec 31 2019)
2019



Total Investments in Millions 107 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions -7 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -6.78 % - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SIGAQ's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SIGAQ's Competitors
Subscribers only: Roi for Siga Technologies Inc's Suppliers
Subscribers only: Return On Investment for SIGAQ's Customers

Other Ratios
SIGAQ's Roa SIGAQ's Inventory Turnover Ratio SIGAQ's Growth Rates SIGAQ's Dividend Statistics
SIGAQ's Profitability Ratios SIGAQ's Asset Turnover Ratio SIGAQ's Dividend Growth
SIGAQ's Roe SIGAQ's Valuation Ratios SIGAQ's Financial Strength Ratios SIGAQ's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2019, within Healthcare Sector ROI
Zomedica Corp   611.96 %
Tuhura Biosciences Inc   489.26 %
Exagen Inc   472.18 %
Oyster Point Pharma Inc   457.62 %
Black Diamond Therapeutics Inc   398.87 %
Trillium Therapeutics Inc   359.16 %
Xbiotech Inc   288.29 %
Progyny Inc   282.27 %
Check Cap Ltd  208.78 %
Quoin Pharmaceuticals Ltd   166.78 %
Semler Scientific inc   152.40 %
Tenax Therapeutics Inc   113.26 %
Rapt Therapeutics Inc   98.39 %
Altamira Therapeutics Ltd   89.97 %
Morphic Holding inc   84.53 %
Jounce Therapeutics inc   69.85 %
Orgenesis Inc   68.81 %
Molecular Templates Inc   65.27 %
Novo Nordisk A  58.34 %
Surgalign Holdings Inc   51.94 %
Zynex inc   50.39 %
Palatin Technologies Inc   48.31 %

Date modified: 2026-09-26T08:35:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.